UNIGE document Scientific Article
previous document  unige:45343  next document
add to browser collection

Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154

Molano, R Damaris
Pileggi, Antonello
Poggioli, Raffaella
Zahr, Elsie
Oliver, Robert
Ricordi, Camillo
Rothstein, David M
show hidden authors show all authors [1 - 10]
Published in Diabetes. 2003, vol. 52, no. 4, p. 957-64
Abstract Clinical islet transplantation is a successful procedure that can improve the quality of life in recipients with diabetes. A drawback of the procedure is the need for chronic administration of immunosuppressive drugs that, among other side effects, are potentially diabetogenic. Definition of immunosuppressive protocols that utilize nondiabetogenic compounds could further improve islet transplantation outcome. We used the NOD mouse to assess the effect of targeting the T-lymphocyte surface receptors CD45RB and CD154 in preventing loss of allogeneic islet grafts as a result of recurrence of autoimmunity and allorejection. Administration of the two antibodies led to significantly prolonged allograft survival, with a percentage of grafts surviving long-term. The therapeutic efficacy of the treatment was paralleled by a shift in CD45RB isoform expression on T-lymphocytes, increased in vitro responsiveness to interleukin-7, and increased in vitro gamma-interferon production after anti-CD3 antibody stimulation. Furthermore, graft infiltration by CD8+ T-cells was remarkably reduced. Recipient mice bearing functioning allografts were otherwise immunocompetent, as assessed in vivo and in vitro by numerous tests, including intragraft cytokine production, responsiveness to polyclonal stimulation and alloantigens, and analysis of cell subset phenotype. These data show that nondiabetogenic regimens of immunomodulation can lead to prolonged islet allograft survival in the challenging NOD mouse model.
Keywords AnimalsAntibodies, Monoclonal/administration & dosageAntigens, CD3/immunologyAntigens, CD45/immunologyCD40 Ligand/immunologyCD8-Positive T-Lymphocytes/immunologyFemaleGraft SurvivalInterferon-gamma/biosynthesis/geneticsInterleukin-10/geneticsInterleukin-2/geneticsInterleukin-7/pharmacologyIslets of Langerhans TransplantationLymphocyte ActivationMiceMice, Inbred NODRNA, Messenger/analysisTransplantation, Homologous
PMID: 12663467
Full text
Article (Published version) (281 Kb) - public document Free access
Research group La transplantation d'îlots de Langerhans (623)
(ISO format)
MOLANO, R Damaris et al. Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. In: Diabetes, 2003, vol. 52, n° 4, p. 957-64. doi: 10.2337/diabetes.52.4.957 https://archive-ouverte.unige.ch/unige:45343

401 hits



Deposited on : 2015-01-15

Export document
Format :
Citation style :